Lidocaine Infusion in Hystroscopy

Lidocaine Infusion Versus Oral Diclofenac During Outpatient Hystroscopy: A Randomized Clinical Trial

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03825016

Enrollment

Registered

2019-01-31

Start date

2017-08-01

Completion date

2020-01-10

Last updated

2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Lidocaine infusion in hystroscopic media versus oral diclofenac

Interventions

DRUGLidocaine Hydrochloride

Lidocaine infusion on hystroscopic media during office hystroscopy

DRUGDiclofenac Sodium

Oral Diclofenac Sodium

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* Age 18-35 years * BMI 18.5-30 kg/m2 * Diagnostic hystroscope

Exclusion criteria

* Previous cervical surgery * Cervical stenosis * PID * allergy to NSAID * Gastritis or peptic ulcer

Design outcomes

Primary

Measure	Time frame	Description
Degree of pain measured by visual analogue scale	1 hour	measured by visual analogue scale

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026